<DOC>
	<DOCNO>NCT01796899</DOCNO>
	<brief_summary>To investigate bioavailability/bioequivalence Brivaracetam oral tablet ( 10 mg , 50 mg , 75 mg 100 mg ) Brivaracetam intravenous injection ( 100 mg ) healthy volunteer .</brief_summary>
	<brief_title>Comparison Brivaracetam Oral Tablet ( 10 mg , 50 mg , 75 mg 100 mg ) Brivaracetam Injection ( 100 mg ) Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Subject healthy male female volunteer age 1855 year inclusive Subject Body Mass Index ( BMI ) 18.0 30.0 kg/m^2 weight least 50 kg ( male ) 45 kg ( female ) Subject normal vital sign value , Electrocardiograms ( ECGs ) clinical laboratory value Female subject negative pregnancy test nonchildbearing potential Volunteer participate participate clinical study investigational drug another Investigational Medicinal Product ( IMP ) within last 3 month Volunteer healthy ( eg , take drug treatment , excessive amount alcohol , cigarettes caffeine , medical emotional/psychological problem , drug/alcohol abuse , abnormal safety parameter ) Subject intolerance allergy compound relate drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Brivaracetam</keyword>
</DOC>